...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >PREPARATION AND CHARACTERIZATION OF CINNARIZINE FLOATING OIL ENTRAPPED CALCIUM ALGINATE BEADS
【24h】

PREPARATION AND CHARACTERIZATION OF CINNARIZINE FLOATING OIL ENTRAPPED CALCIUM ALGINATE BEADS

机译:肉桂酸浮游油包裹的海藻酸钙珠的制备与表征

获取原文

摘要

Gastroretentive delivery systems can be retained in the stomach and assist in improving absorption and consequently the bioavailability of drug that has a narrow absorption window in a particular region of gastrointestinal tract. A floatable multiparticulate system with potential for intragastric sustained delivery is one of the approaches to get the gastroretention. Cinnarizine(CNZ), an antihistaminic drug used in vertigo caused by meniere’s disease was taken as a model drug for floating beads prepared by non effervescent method. Floating CNZ olive oil-entrapped emulsion gel beads were prepared by the emulsion–gelation method. Different concentrations of sodium alginate (1%, 2%, and 3% w/v), oil (5%, 10%, and 15% v/v), and calcium chloride (0.02, 0.1, and 0.5M) were used and their influence on beads uniformity, buoyancy, and in vitro drug release was studied. The results indicated that retardation of drug release was achieved by the oil hydrophobic diffusion barrier, especially in the presence of the compact network of alginate beads. The selected formula of calcium alginate beads using 3% w/v sodium alginate, 15% v/v oil and 0.1 M calcium chloride, showed a higher similarity factor (f2 =70.1) of CNZ release in comparison to release from standard gastroretentive sustained release floating cinnarizine tablet with good floating over duration of more than 12 hours.
机译:胃滞留递送系统可以保留在胃中,并有助于改善吸收,从而改善在胃肠道特定区域具有狭窄吸收窗口的药物的生物利用度。具有胃内持续递送潜力的可漂浮多颗粒系统是获得胃滞留的方法之一。 Cinenarizine(CNZ)是一种用于治疗由美尼尔氏病引起的眩晕的抗组胺药,被用作非泡腾法制备的漂浮珠的模型药物。通过乳液-凝胶化方法制备了漂浮的CNZ橄榄油包裹的乳液凝胶珠。使用了不同浓度的海藻酸钠(1%,2%和3%w / v),油(5%,10%和15%v / v)和氯化钙(0.02、0.1和0.5M)并研究了它们对微珠均匀性,浮力和体外药物释放的影响。结果表明,通过油性疏水扩散屏障实现了药物释放的阻滞,特别是在藻酸盐珠粒的致密网络存在下。使用3%w / v海藻酸钠,15%v / v油和0.1 M氯化钙选择的海藻酸钙珠配方,显示CNZ释放的较高相似因子(f 2 = 70.1)。与从标准胃滞性缓释浮动桂那利嗪片中释放出来的比较,该片在超过12小时的时间内具有良好的漂浮性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号